![\"CSL](\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/08\/1787251873_166_d168161e958524b84e9991444ddb45374d3be6f6-91929648.jpg\")
<\/p>\n <\/p>\n
CSL Behring is cutting fewer than ten per cent of its jobs <\/p>\n
Keystone-SDA <\/p>\n
The Australian pharmaceutical group CSL Behring has cut just under 10% of the workforce in Bern, the company announced on Thursday.\n<\/p>\n
Listen to the article <\/p>\n
Listening the article <\/p>\n
Toggle language selector <\/p>\n
English (US) <\/p>\n
English (British) <\/p>\n
Generated with artificial intelligence. <\/p>\n
This content was published on <\/p>\n
August 20, 2026 – 17:05\n<\/p>\n
In February, it emerged that the company was planning job cuts. Tamedia\u2019s Bern-based publications cited a figure of around 180 jobs likely to be at risk \u2013 roughly 10% of the workforce.<\/p>\n
CSL Behring has now stated in a press release issued on Thursday that the transformation process has been completed and that the company has \u201cstrengthened its long-term competitiveness and positioned itself for the future\u201d.<\/p>\n
+ Pharma company CSL Behring plans Swiss job cuts<\/a><\/p>\n As part of the change process, more than 100 new positions have been created, enabling many employees to move into new roles within the company. \u201cThanks to the great commitment of everyone involved at the site, job cuts were limited to less than 10% of the workforce,\u201d the statement said. The group did not disclose any more specific figures in its statement.<\/p>\n The CSL Behring site in Bern is one of the region\u2019s largest industrial employers and remains one of the group\u2019s most important production sites worldwide.<\/p>\n +\u00a0How we produce news in English<\/a>
Translated from German, reviewed by an\u00a0English Department<\/a>\u00a0journalist.<\/p>\n","protected":false},"excerpt":{"rendered":"CSL Behring is cutting fewer than ten per cent of its jobs Keystone-SDA The Australian pharmaceutical group CSL…\n","protected":false},"author":2,"featured_media":118105,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[10],"tags":[101,596,629,104,114,1002,100,103,102,630],"class_list":["post-118104","post","type-post","status-publish","format-standard","has-post-thumbnail","category-bern","tag-article","tag-beat-healthcare-innovation","tag-beat-workplace","tag-bern","tag-business","tag-health","tag-latest-news","tag-production-type-deepl-autotranslation","tag-sda-ready-to-publish","tag-work"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117129349903852145","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/118104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=118104"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/118104\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/118105"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=118104"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=118104"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=118104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}